Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study

References

• Kim HH, Ryu J. Social distancing attitudes, national context, and health outcomes during the COVID-19 pandemic: findings from a global survey. Prev Med. 2021;148:106544. doi:10.1016/j.ypmed.2021.106544
   PubMed Web of Science ®Google Scholar
• Lindinger-Sternart S, Kaur V, Widyaningsih Y, Patel AK. COVID-19 phobia across the world: impact of resilience on COVID-19 phobia in different nations. Couns Psychother Res. 2021;21(2):290–302. doi:10.1002/capr.12387
   PubMed Web of Science ®Google Scholar
• Nayak J, Mishra M, Naik B, Swapnarekha H, Cengiz K, Shanmuganathan V. An impact study of COVID-19 on six different industries: automobile, energy and power, agriculture, education, travel and tourism and consumer electronics. Expert Syst. 2021. doi:10.1111/exsy.12677
   PubMed Web of Science ®Google Scholar
• Aschwanden C. Five reasons why COVID herd immunity is probably impossible. Nature. 2021;591(7851):520–522. doi:10.1038/d41586-021-00728-2
   PubMed Web of Science ®Google Scholar
• Mirtaleb MS, Mirtaleb AH, Nosrati H, Heshmatnia J, Falak R, Zolfaghari Emameh R. Potential therapeutic agents to COVID-19: an update review on antiviral therapy, immunotherapy, and cell therapy. Biomed Pharmacother. 2021;138:111518. doi:10.1016/j.biopha.2021.111518
   PubMed Web of Science ®Google Scholar
• Karki N, Verma N, Trozzi F, Tao P, Kraka E, Zoltowski B. Predicting Potential SARS-COV-2 drugs-in depth drug database screening using deep neural network framework SSnet, classical virtual screening and docking. Int J Mol Sci. 2021;22(4):1573. doi:10.3390/ijms22041573
   PubMed Web of Science ®Google Scholar
• McKee DL, Sternberg A, Stange U, Laufer S, Naujokat C. Candidate drugs against SARS-CoV-2 and COVID-19. Pharmacol Res. 2020;157:104859. doi:10.1016/j.phrs.2020.104859
   PubMed Web of Science ®Google Scholar
• Zhang DH, Wu KL, Zhang X, Deng SQ, Peng B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J Integr Med. 2020;18(2):152–158. doi:10.1016/j.joim.2020.02.005
   PubMed Web of Science ®Google Scholar
• Smith M, Smith JC. Repurposing therapeutics for COVID-19: supercomputer-based docking to the SARS-CoV-2 viral spike protein and viral spike protein-human ACE2 interface. ChemRxiv. 2020. doi:10.26434/chemrxiv.11871402.v3
   Google Scholar
• Williamson G, Kerimi A. Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction. Biochem Pharmacol. 2020;178:114123. doi:10.1016/j.bcp.2020.114123
   PubMed Web of Science ®Google Scholar
• Pandey P, Rane JS, Chatterjee A, et al. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in-silico study for drug development. J Biomol Struct Dyn. 2020:1–11. doi:10.1080/07391102.2020.1796811.
   Web of Science ®Google Scholar
• Khaerunnisa S, Kurniawan H, Awaluddin R, Suhartati S, Soetjipto S. Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints. 2020. doi:10.20944/preprints.202003.0226.v1
   Google Scholar
• Abian O, Ortega-Alarcon D, Jimenez-Alesanco A, et al. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. Int J Biol Macromol. 2020;164:1693–1703. doi:10.1016/j.ijbiomac.2020.07.235
   PubMed Web of Science ®Google Scholar
• Anand David AV, Arulmoli R, Parasuraman S. Overviews of biological importance of quercetin: a bioactive flavonoid. Pharmacogn Rev. 2016;10(20):84–89. doi:10.4103/0973-7847.194044
   PubMedGoogle Scholar
• Gao L, Liu G, Wang X, Liu F, Xu Y, Ma J. Preparation of a chemically stable quercetin formulation using nanosuspension technology. Int J Pharm. 2011;404(1–2):231–237. doi:10.1016/j.ijpharm.2010.11.009
   PubMed Web of Science ®Google Scholar
• Wang W, Sun C, Mao L, et al. The biological activities, chemical stability, metabolism, and delivery systems of quercetin: a review. Trends Food Sci Technol. 2016;56:21–38. doi:10.1016/j.tifs.2016.07.004
   Web of Science ®Google Scholar
• Riva A, Ronchi M, Petrangolini G, Bosisio S, Allegrini P. Improved oral absorption of quercetin from quercetin Phytosome®, a new delivery system based on food grade lecithin. Eur J Drug Metab Pharmacokinet. 2019;44(2):169–177. doi:10.1007/s13318-018-0517-3
   PubMed Web of Science ®Google Scholar
• Derosa G, Maffioli P, D’Angelo A, Di Pierro F. A role for quercetin in coronavirus disease 2019 (COVID-19). Phytother Res. 2021;35(3):1230–1236. doi:10.1002/ptr.6887
   PubMed Web of Science ®Google Scholar
• Di Pierro F, Khan A, Bertuccioli A, et al. Quercetin Phytosome® as a potential candidate for managing COVID-19. Minerva Gastroenterol Dietol. 2020. doi:10.23736/S1121-421X.20.02771-3
   Google Scholar
• Batiha GE, Beshbishy AM, Ikram M, et al. The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin. Foods. 2020;9(3):374. doi:10.3390/foods9030374
   PubMed Web of Science ®Google Scholar
• Gautam N, Madathil S, Tahani N, et al. Medium-term outcome of severe to critically ill patients with SARS-CoV-2 infection. Clin Infect Dis. 2021. doi:10.1093/cid/ciab341
   PubMed Web of Science ®Google Scholar
• Almatroodi SA, Alsahli MA, Almatroudi A, et al. Potential therapeutic targets of quercetin, a plant flavonol, and its role in the therapy of various types of cancer through the modulation of various cell signaling pathways. Molecules. 2021;26(5):1315. doi:10.3390/molecules26051315
   PubMed Web of Science ®Google Scholar
• Patel RV, Mistry BM, Shinde SK, Syed R, Singh V, Shin HS. Therapeutic potential of quercetin as a cardiovascular agent. Eur J Med Chem. 2018;155:889–904. doi:10.1016/j.ejmech.2018.06.053
   PubMed Web of Science ®Google Scholar
• Iqbal M, Ho HL, Petropoulos S, Moisiadis VG, Gibb W, Matthews SG. Pro-inflammatory cytokine regulation of P-glycoprotein in the developing blood-brain barrier. PLoS One. 2012;7(8):e43022. doi:10.1371/journal.pone.0043022
   PubMed Web of Science ®Google Scholar
• Pawar A, Pal A. Molecular and functional resemblance of dexamethasone and quercetin: a paradigm worth exploring in dexamethasone-nonresponsive COVID-19 patients. Phytother Res. 2020;34(12):3085–3088. doi:10.1002/ptr.6886
   PubMed Web of Science ®Google Scholar
• Pal A, Squitti R, Picozza M, et al. Zinc and COVID-19: basis of current clinical Trials. Biol Trace Elem Res. 2020;1–11. doi:10.1007/s12011-020-02437-9
   Web of Science ®Google Scholar
• Xu D, Hu MJ, Wang YQ, Cui YL. Antioxidant activities of quercetin and its complexes for medicinal application. Molecules. 2019;24(6):1123. doi:10.3390/molecules24061123
   PubMed Web of Science ®Google Scholar
• Heinz SA, Henson DA, Austin MD, Jin F, Nieman DC. Quercetin supplementation and upper respiratory tract infection: a randomized community clinical trial. Pharmacol Res. 2010;62(3):237–242. doi:10.1016/j.phrs.2010.05.001
   PubMed Web of Science ®Google Scholar
• Luo E, Zhang D, Luo H, et al. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China. Chin Med. 2020;15(1):34. doi:10.1186/s13020-020-00317-x
   PubMed Web of Science ®Google Scholar
• Brito JCM, Lima WG, Cordeiro LPB, da Cruz Nizer WS. Effectiveness of supplementation with quercetin-type flavonols for treatment of viral lower respiratory tract infections: systematic review and meta-analysis of preclinical studies. Phytother Res. 2021. doi:10.1002/ptr.7122
   Web of Science ®Google Scholar